田建辉治疗恶性肿瘤及其合并症常用药对-药组撷菁  

Tian Jianhui's commonly used herb pairs and herb groups in treating malignant tumors and their comorbidities

作　　者：李佳轩 罗斌[1] 冯茜[2] 田建辉[1] LI Jiaxuan;LUO Bin;FENG Qian;TIAN Jianhui(Oncology Clinical Medicine Center,Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to ShanghaiUniversity of Traditional Chinese Medicine/Oncology Research Institute,Shanghai Municipal Hospital of TraditionalChinese Medicine,Shanghai 200071,China;Department of Tuberculosis,Putuo Hospital Affiliated to ShanghaiUniversity of Traditional Chinese Medicine,Shanghai 200062,China)

机构地区：[1]上海中医药大学附属市中医医院肿瘤临床医学中心/上海市中医医院肿瘤研究所,上海200071 [2]上海中医药大学附属普陀医院结核病科,上海200062

出　　处：《上海中医药杂志》2024年第12期95-99,共5页Shanghai Journal of Traditional Chinese Medicine

基　　金：国家中医药管理局第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号);上海市卫健委领军人才项目(2022LJ014)。

摘　　要：介绍田建辉教授治疗恶性肿瘤及其合并症的常用药对-药组,探讨其组方思路及用药特色。认为恶性肿瘤核心病机为正虚伏毒、神机失用,临证强调扶正治癌、形神并调的重要性,形成“扶正治癌”药组、“调神治癌”药组、“蠲毒抑癌”药组;提出恶性肿瘤本身与其并发(病)症之间存在共性病机,主张以证统病,病证结合,随症加减,从而形成治疗恶性肿瘤相关性疾病核心药组。This article introduces the commonly used herb pairs and herb groups by Professor Tian Jianhui in the treatment of malignant tumors and their comorbidities,and discusses his approach to formulation and unique characteristics in medication use.Professor Tian identifies the core pathogenesis of malignant tumors as vital qi deficiency and latent toxins as well as malfunction of the spirit mechanism.His clinical practice emphasizes the importance of supporting the body's vital qi to treat cancer and balancing the form and spirit.He has developed three main herb groups:"Fuzheng Zhiai(strengthening vital qi to treat cancer)"group,"Tiaoshen Zhiai(regulating the spirit to treat cancer)"group,and"Juandu Yiai(detoxifying and suppressing cancer)"group.Additionally,he proposes that malignant tumors and their comorbidities share common pathogenesis.Therefore,he advocates to integrate comorbidities through syndrome differentiation,combine disease diagnosis with syndrome differentiation,and adjust treatment based on symptoms,thereby forming core herb groups for treating malignancy-related diseases.

关 键 词：恶性肿瘤 药对 药组 临床应用 中医药疗法 

分 类 号：R273[医药卫生—中西医结合]